Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.
about
Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answersAnticardiolipin antibodies in spontaneously hypertensive rats (SHR), stroke-prone SHR and normal Wistar rats.Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series.The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.Chorea and high antiphospholipid antibodies: probable primary antiphospholipid syndrome.Vascular- and pregnancy-related outcomes in patients with systemic lupus erythematosus with positive antiphospholipid profile and thrombocytopenia.Association of anti-phospholipid antibodies with connective tissue diseases.Current treatment of antiphospholipid syndrome: lights and shadows.'Primary', 'secondary' and other variants of the antiphospholipid syndrome.Hepatic infarction in a pregnant patient with the 'primary' antiphospholipid syndrome.Presence of multiple anti-phospholipid antibody specificities in a pediatric population.Origin and pathogenesis of antiphospholipid antibodies.Antiphospholipid syndrome: linking many specialties.Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.Life-threatening right ventricular thrombosis in association with phospholipid antibodies.Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome.Migraine and haemostasis.Antiphospholipid syndrome: an overview.Antiphospholipid syndrome: multiple mechanisms.Recognizing antiphospholipid syndrome. Case report: misdiagnosis delayed treatment.Prevalence of anticardiolipin antibodies in the elderly British population.Antiphospholipid antibodies: laboratory and pathogenetic aspects.'Overlap' syndromes.Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort.The antiphospholipid syndrome: from pathophysiology to treatment.Anticardiolipin antibodies in leptospirosis.Massive lower extremity arterial thrombosis and acute hepatic insufficiency in a young adult with premature atherosclerosis associated with hyperlipoprotein(a)emia and antiphospholipid syndrome. A case report.Antiphospholipid syndrome within systemic lupus erythematosus.Antiphospholipid antibody testing in patients with pregnancy loss.The concept and classification of antiphospholipid/cofactor syndromes.Occlusive ocular vascular disease and antiphospholipid antibodies.Antiphospholipid syndrome: five year follow up.Antiphospholipid antibodies: which and when?Central serous chorioretinopathy and antiphospholipid antibodies--results of a pilot study.Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome.Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
P2860
Q28196276-3186C44D-1569-405A-BEF4-6271FABDBC90Q33333956-A6C0C508-E2C4-4DEB-A4F2-F9380C046923Q33341941-6D42994C-D31F-46E3-9F78-C36D73B17F8DQ33358817-5A5A7005-6CBC-4A5A-868B-D00EBDAD7B82Q33371184-1B25F90F-1EC9-4394-AAB4-78D4630143F4Q33388194-3F96F389-154E-47EB-93BC-4AEBD177838FQ33394044-CAED074A-CA30-407D-A0F8-63E072988C95Q33401106-37A2FC3B-B303-435B-A562-D909F251B98CQ33411761-D1B788FD-EC8A-428C-8CA3-67987FF15F34Q33419495-3581EC00-572D-4232-8467-D1C5FCF3F4A7Q33421547-440FD20C-A56C-4D8D-9558-FA33C78CBEEAQ33423959-4A906554-E9AF-4958-801B-850624090C82Q33490042-034A7EBB-8B9A-4B6A-B703-85EF2C128E51Q33493322-3D965EC4-4AC8-4885-8099-07E2F3C53A07Q33496099-33098B9B-3E90-48F9-A746-85AD73D0E16AQ33503275-735DB5E3-078D-4448-8B9E-E79648817FA3Q33561642-F41CA66C-CD37-47D2-8317-B798C7665BDCQ33564539-8C6E6A5F-287E-4EA0-B2E8-591EA4C4CC7CQ33613382-4D1492EE-672D-4986-ADBF-FE0BFBA7A3ECQ33826408-82905EC7-4F3D-40CF-93F9-E2ADC5E7A331Q34352811-3B069412-9207-4DBE-8D6F-07AEEF3B9113Q35099505-C5262225-08E1-4F3F-B958-098EBBAE6113Q35775322-3A0AEBA8-29D1-42EA-8F3D-12322A8F295CQ36284730-ECA51D6E-E4DB-4D08-94A1-8CFD9BB504BAQ36681618-7341D87F-1E71-472F-AD04-0A44F700F146Q36799474-F46EFB04-6D6F-4EC9-AB1C-C219E92309D9Q38008403-28E899DA-08F8-480D-ADFB-A0D1A4E86C34Q38458903-39E90372-9E41-4494-AD56-BED62DB4B448Q38873953-4FA233A0-CEAB-4701-ABA5-8CF4706B14FDQ39458375-426E3427-5EBC-4130-9405-F392275D735AQ40474895-5B938D67-0FD9-47E7-B8D0-7EBC06067BCCQ40558532-D798611D-4E80-4C4D-B1E8-819FEDCD13D6Q40583137-2B124799-5100-441D-A5B1-E4D9630E08D2Q41197406-2564C5DF-C5F0-4B1D-91B3-A414A73D45FFQ41220259-00FA1D5E-803F-47FC-8635-5F3E360EF3F3Q41241672-D49970D4-204F-4643-AE0A-A65248059576Q42778868-1352B50A-5491-4966-8F3A-C4C8B30B4E2DQ44787262-A972730E-4BB9-45B2-95A8-0F15EE6C11B1Q46115743-BF353FC8-755D-4132-87AD-32EA27717786Q48159962-0AB44392-ABC8-4935-B319-CC94B53549A7
P2860
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@ast
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@en
type
label
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@ast
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@en
prefLabel
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@ast
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@en
P2860
P356
P1476
Primary antiphospholipid syndr ...... ibodies and no other disorder.
@en
P2093
Mackworth-Young CG
P2860
P304
P356
10.1136/ARD.48.5.362
P407
P50
P577
1989-05-01T00:00:00Z